These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 401727)

  • 1. Drug interactions with oral sulphonylurea hypoglycaemic drugs.
    Hansen JM; Christensen LK
    Drugs; 1977 Jan; 13(1):24-34. PubMed ID: 401727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug interactions of gliclazide and other sulfonylureas in protein binding in vitro and in hypoglycemic effect in rats.
    Fujii T; Nakamura K; Furukawa H; Watanabe M; Kuwashima J; Miyazaki H; Kawashima K; Kuzuya T
    Arzneimittelforschung; 1983; 33(11):1535-7. PubMed ID: 6686448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ["First" and "second" generation sulfonylureas: distinction or difference? (author's transl)].
    Balant L
    Diabete Metab; 1978 Jun; 4(2):135-43. PubMed ID: 98364
    [No Abstract]   [Full Text] [Related]  

  • 4. The pharmacology of a new hypoglycaemic agent N-[4-(2-(2,3-dihydrobenzo(b)furan-7-carboxamid o)-ethyl)-benzenesulphonyl]-N'-cyclohexlurea (NOVO CS 476). III. General pharmacological studies.
    Jorgensen KD
    Acta Pharmacol Toxicol (Copenh); 1977 Feb; 40(2):234-40. PubMed ID: 402792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Extrapancreatic effects of sulfonylurea compounds. IV. Increase of the effect of insulin due to tolbutamide, glibornuride, and glibenclamide in vitro].
    Beyer J; Gather W; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2179. PubMed ID: 4198966
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug interactions with coumarin anticoagulants. 2.
    Weser JK; Sellers E
    N Engl J Med; 1971 Sep; 285(10):547-58. PubMed ID: 4397794
    [No Abstract]   [Full Text] [Related]  

  • 7. Sulfonylureas stimulate renin secretion from the perfused kidney of the rat.
    Ochi H; Ikeda T
    Nephron; 1999 Jan; 81(1):67-71. PubMed ID: 9884422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mode of action of oral hypoglycaemic agents. II. Sulphonylureas & biguanides in rats.
    Augusti KT; Kurup PA
    Indian J Biochem; 1969 Mar; 6(1):36-9. PubMed ID: 4332123
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibitory effect of anti-diabetic agents on rat organic anion transporter rOAT1.
    Uwai Y; Saito H; Hashimoto Y; Inui K
    Eur J Pharmacol; 2000 Jun; 398(2):193-7. PubMed ID: 10854830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of metformin on BRIN-BD11 beta-cell insulin secretory desensitization induced by prolonged exposure to sulphonylureas.
    Irwin N; McKinney JM; Bailey CJ; Flatt PR; McClenaghan NH
    Diabetes Obes Metab; 2010 Dec; 12(12):1066-71. PubMed ID: 20977577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New aspects of therapy with oral antidiabetic agents].
    Haslbeck M
    Wien Med Wochenschr; 1979 Dec; 199(24):689-95. PubMed ID: 161940
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacologic study with glisoxepide and other blood sugar reducing sulfonamide derivatives in metabolically healthy subjects and diabetics].
    Haupt E; Beyer J; Schöffling K
    Arzneimittelforschung; 1974 Mar; 24(0):418-25. PubMed ID: 4211557
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide).
    Loubatiéres A; Mariani MM; Ribes G; Alric R
    Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200675
    [No Abstract]   [Full Text] [Related]  

  • 14. Insulinotrophic drugs. Effect on intestinal abosorption of sugar.
    Botros M; Selim R; Ghoneim K; Ghareeb A; Wahba N
    Diabetes; 1974 Feb; 23(2):112-6. PubMed ID: 4204422
    [No Abstract]   [Full Text] [Related]  

  • 15. [Extrapancreatic effects of sulfonylurea compounds. 3. Studies on the additional blood sugar decreasing and antilipolytic effect of tolbutamide, glibornuride, and glibenclamide on completely pancreatectomized dogs, chronically treated with insulin during acute experiment and following pretreatment with sulfonylurea compounds using small doses of sulfonylurea].
    Beyer J; Cordes U; Sell G; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2176. PubMed ID: 4198965
    [No Abstract]   [Full Text] [Related]  

  • 16. Leukocytoclastic vasculitis induced by use of glyburide: a case of possible cross-reaction of a sulfonamide and a sulfonylurea.
    Bukhalo M; Zeitouni NC; Cheney RT
    Cutis; 2003 Mar; 71(3):235-8. PubMed ID: 12661752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure vs. activity in the sulfonylurea-mediated disulfiram-ethanol reaction.
    Nagasawa HT; DeMaster EG; Kwon CH; Fraser PS; Shirota FN
    Alcohol; 1985; 2(1):123-8. PubMed ID: 4015826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glibenclamide is exceptional among hypoglycaemic sulphonylureas in accumulating progressively in beta-cell-rich pancreatic islets.
    Hellman B; Sehlin J; Täljedal IB
    Acta Endocrinol (Copenh); 1984 Mar; 105(3):385-90. PubMed ID: 6230850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hypoglycemic agents on liver regeneration.
    Gershbein LL
    Biochem Pharmacol; 1967 Jun; 16(6):1117-20. PubMed ID: 6040393
    [No Abstract]   [Full Text] [Related]  

  • 20. [Inhibition of urease by hypoglycaemic drugs (author's transl)].
    Herrera J; Sabater J; Molina J
    Rev Esp Fisiol; 1977 Mar; 33(1):37-9. PubMed ID: 854647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.